Aventusoft offers Hemotag, a portable, non‑invasive cardiac imaging device that uses AI to capture and analyze high‑resolution heart data, delivering diagnostic reports and disease monitoring without catheters or implants. Its CarePear platform connects patients and primary physicians with U.S. cardiac subspecialists for secure telehealth consultations, while the Trialogy solution enables AI‑driven decentralized clinical trials for life‑science companies. The suite integrates with electronic health records via standard APIs and complies with HIPAA and FDA‑validated AI standards.
Funding
Funding not disclosed
Founders
Product
Problem
Patients with cardiac conditions often require invasive imaging procedures or implantable devices to obtain detailed diagnostic information, which can be costly, carry procedural risks, and limit access to specialist care, especially in underserved areas.
Solution
Aventusoft provides a non‑invasive AI‑powered cardiac imaging device called Hemotag that captures high‑resolution cardiac data without the need for catheters or implants. The device integrates with a cloud‑based digital health platform that applies machine‑learning algorithms to analyze cardiac signals, generate diagnostic reports, and monitor disease progression. Through the CarePear platform, patients and their primary physicians can securely connect with U.S.‑based cardiac subspecialists for remote consultations and treatment planning. Aventusoft also offers the Trialogy solution, which leverages the same AI infrastructure to conduct decentralized clinical trials, enabling life‑science companies to collect cardiac data from distributed participants with reduced site overhead.
Target Audience
Primary customers are cardiology clinics, hospitals, and primary‑care networks seeking non‑invasive cardiac diagnostics, as well as pharmaceutical and biotech firms conducting cardiac clinical research.
Features
- Portable, non‑invasive cardiac imaging hardware with built‑in AI signal processing
- Real‑time AI analysis that produces quantitative cardiac metrics and diagnostic visualizations
- Secure telehealth portal (CarePear) for virtual appointments with U.S. cardiac subspecialists
- Cloud‑native data storage and interoperability with electronic health record systems via standard APIs
- AI‑driven decentralized trial platform (Trialogy) that automates patient enrollment, data capture, and outcome analytics across multiple sites
- Compliance with HIPAA and FDA‑recognized AI validation frameworks for clinical use